Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice.
Stanley Chun Ming WuManyu ZhuStanley C C ChikMaxwell KwokAsif JavedLaalaa LawShing ChanKenneth R BohelerYin Ping LiuGodfrey Chi Fung ChanEllen Ngar Yun PoonPublished in: Stem cell research & therapy (2023)
CD55, by suppressing complement, contributes to the improved protection of AT-hMSCs against aGvHD. The use of AT-hMSCs or the upregulation of CD55 by small molecules thus represents promising new strategies to promote hMSC survival to improve the efficacy of transplantation therapy. As complement injury is a barrier to all types of hMSC therapy, our findings are of broad significance to enhance the use of hMSCs for the treatment of a wide range of disorders.